Oxford
WORLD
Oxford university scientists make significant medical breakthrough
Nearly 26,000 women die from ovarian cancer each year in the European Union. OvarianVax is a promising new vaccine in development that aims to train the immune system to recognize and attack the earliest stages of ovarian cancer. Researchers have secured £600,000 (€719,960) in funding, which will support laboratory research for the next three years, […]
Read More